Bryce Point Capital LLC Purchases Shares of 21,950 Maximus, Inc. (NYSE:MMS)

Bryce Point Capital LLC purchased a new stake in Maximus, Inc. (NYSE:MMS) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 21,950 shares of the health services provider’s stock, valued at approximately $1,639,000.

Several other large investors also recently made changes to their positions in the stock. Trexquant Investment LP boosted its stake in Maximus by 19.8% in the 4th quarter. Trexquant Investment LP now owns 176,003 shares of the health services provider’s stock worth $13,139,000 after purchasing an additional 29,073 shares during the period. Headlands Technologies LLC bought a new stake in shares of Maximus in the fourth quarter valued at about $290,000. Franklin Resources Inc. boosted its position in shares of Maximus by 21.8% during the fourth quarter. Franklin Resources Inc. now owns 6,176 shares of the health services provider’s stock worth $461,000 after buying an additional 1,104 shares during the period. Meeder Asset Management Inc. bought a new position in shares of Maximus during the fourth quarter worth about $1,407,000. Finally, Arrowstreet Capital Limited Partnership raised its position in Maximus by 108.5% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 84,309 shares of the health services provider’s stock valued at $6,294,000 after buying an additional 43,864 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Insider Buying and Selling at Maximus

In related news, insider Ilene R. Baylinson sold 14,500 shares of the firm’s stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now owns 18,097 shares of the company’s stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

Maximus Price Performance

NYSE:MMS opened at $68.64 on Wednesday. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The company has a market cap of $3.88 billion, a P/E ratio of 14.76 and a beta of 0.71. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The stock’s 50-day simple moving average is $69.57 and its 200 day simple moving average is $77.51.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, sell-side analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.75%. The ex-dividend date was Friday, February 14th. Maximus’s dividend payout ratio (DPR) is currently 25.81%.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a report on Thursday, January 2nd.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.